FDA Approves New Antibiotic for Uncomplicated Urinary Tract Infections
Approval of Pivya is for female adults with UTIs caused by susceptible isolates of E. coli, P. mirabilis, and S. saprophyticus
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.